Fundraising

Step Pharma, incubated at #Agoranov in 2014, announces a €35m raise. 👏

After an initial raise for the #biotech in 2017 of €14.5M, Step Pharma closes a Series B to advance their lead CTPS1 inhibitor, STP938, into clinical development for the treatment of T-cell tumors.

For more information: https://lnkd.in/dCVwXyJ.

#deeptech